ストックスクリーナーアプリを入手
15.42
0.06%
-0.010
前日終値:
$15.43
開ける：
$15.43
24時間の取引高:
272.23K
Relative Volume:
0.11
時価総額：
$1.75B
収益：
$260.81M
当期純損益:
$20.48M
株価収益率:
118.62
EPS:
0.13
ネットキャッシュフロー:
$22.67M
1週間 パフォーマンス:
+0.26%
1か月 パフォーマンス:
+41.60%
6か月 パフォーマンス:
+49.71%
1年 パフォーマンス:
+20.19%
1日の値動き範囲:
$15.41
$15.43
1週間の範囲:
$15.37
$15.44
52週間の値動き範囲:
$9.20
$15.49
Dynavax Technologies Corp Stock (DVAX) Company Profile
名前
Dynavax Technologies Corp
セクター
電話
(510) 848-5100
住所
2100 POWELL STREET, EMERYVILLE, CA
DVAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
15.43 | 1.75B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
127.88 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.96 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.06 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.46 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.33 | 21.64B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | ダウングレード | Goldman | Neutral → Sell |
| 2024-02-01 | 開始されました | Goldman | Neutral |
| 2022-09-27 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-01-06 | 再開されました | Goldman | Buy |
| 2021-08-06 | 開始されました | Goldman | Buy |
| 2020-08-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-15 | 開始されました | Evercore ISI | Outperform |
| 2019-10-18 | 開始されました | H.C. Wainwright | Buy |
| 2019-07-11 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-05-10 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-03-08 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-09-25 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-31 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-07-31 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2013-11-25 | アップグレード | MLV & Co | Hold → Buy |
| 2013-02-25 | ダウングレード | MLV & Co | Buy → Hold |
| 2012-11-16 | 繰り返されました | MLV & Co | Buy |
すべてを表示
Dynavax Technologies Corp (DVAX) 最新ニュース
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF - GlobeNewswire Inc.
Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights - Finviz
Dynavax Technologies Corporation (NASDAQ:DVAX) Surges 42% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ - marketscreener.com
Evaluating Dynavax (DVAX) After Its Recent Share Price Rally: Is the Stock Still Undervalued? - simplywall.st
Pacer Advisors Inc. Grows Holdings in Dynavax Technologies Corporation $DVAX - MarketBeat
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies CorporationDVAX - The Malaysian Reserve
Sanofi Acquires Emeryville's Dynavax Technologies for $2.2 Billion, Bolstering Vaccine Portfolio Amid Industry Optimism - Hoodline
Sanofi adds HBV vaccine, shingles candidate via Dynavax takeout: Deals Report - BioCentury
CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies CorporationDVAX - Business Wire
Dynavax (DVAX) rockets 38% on Sanofi $2-billion merger - MSN
Insider Selling: Dynavax Technologies (NASDAQ:DVAX) COO Sells 30,000 Shares of Stock - MarketBeat
Dynavax Technologies (NASDAQ:DVAX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Emeryville's Dynavax accepts $2.2 billion buyout from Sanofi following year of investor pressure - The Business Journals
Dynavax Technologies Signs Agreement and Plan of Merger With Sanofi - TradingView — Track All Markets
Sanofi Agrees to Buy Dynavax for $2.2 Billion After FDA MS Drug Rejection - GuruFocus
Small Cap Stocks To Keep An Eye OnDecember 25th - MarketBeat
Sanofi (SNY) to Acquire Dynavax Technologies Corporation (DVAX) - Insider Monkey
Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal - MSN
Exchange Traded Concepts LLC Has $2 Million Stake in Dynavax Technologies Corporation $DVAX - MarketBeat
Dynavax Technologies (NASDAQ:DVAX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Small Cap Stocks To Follow TodayDecember 24th - MarketBeat
Biggest stock movers Wednesday: DVAX, NKE, INTC, and more - MSN
Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus - Sahm
Nvidia, Sobr Safe And 3 Stocks To Watch Heading Into Friday - Benzinga
Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger - Insider Monkey
Assessing Dynavax After a 42% Surge and Strong HEPLISAV B Growth in 2025 - Yahoo Finance
Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why - Benzinga
NKE, OMER, MU, INTC, DVAX: 5 Trending Stocks TodayNike (NYSE:NKE) - Benzinga
Stock Movers: Intel, Dynavax, Snowflake - Bloomberg.com
Why Dynavax Stock Soared Today - Finviz
Sanofi to Buy Dynavax for $2.2 Billion in Cash Deal - USA Herald
Dynavax Stock Climbs: Is It Time to Ride the Wave? - StocksToTrade
Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition - MedCity News
European Stocks Close Mixed in Wednesday Trading; Sanofi to Acquire Dynavax Technologies - marketscreener.com
Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal By Reuters - Investing.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sanofi paying $2.2B for Dynavax; tolebrutinib CRL lands - BioWorld MedTech
Dynavax Technologies Stock Soars on Buyout Buzz - Schaeffer's Investment Research
Sanofi to Acquire Dynavax for $2.2 Billion, Expanding Vaccine Portfolio - Yahoo Finance
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise - Finviz
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion - Yahoo Finance
Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying - Yahoo Finance
Watch Intel Declines; Dynavax Rallies; Nike Ticks Higher - Bloomberg.com
Intel Stock Slides as Nvidia Pauses 18A Testing; Nike Jumps on Tim Cook Buy and Dynavax Soars on Sanofi Deal - ts2.tech
Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter - Stocktwits
Sanofi Buys Dynavax for $2.2 Billion to Boost Vaccine Lineup - Bloomberg.com
Dynavax Technologies stock hits 52-week high at 15.48 USD - Investing.com
Dynavax Technologies stock hits 52-week high at 15.48 USD By Investing.com - Investing.com Canada
Sanofi to Buy Dynavax in $2.2 Billion Cash Deal - marketscreener.com
Sanofi to acquire Dynavax in $2.2B deal to boost adult vaccines - Proactive financial news
Dynavax Technologies Corp (DVAX) 財務データ
収益
当期純利益
現金流量
EPS
1.35%
2.56%
大文字化:
|
ボリューム (24 時間):